-

SHAREHOLDER ALERT: Robbins LLP Announces That 3D Systems Corp. (DDD) is Being Sued for Misleading Shareholders

SAN DIEGO & ROCK HILL, S.C.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of 3D Systems Corp. (NYSE: DDD) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between May 6, 2020 and March 1, 2021. 3D Systems provides comprehensive 3D printing and digital manufacturing services and digital design tools.

If you suffered a loss due to 3D Systems Corp.'s misconduct, click here.

3D Systems Corp. (DDD) Lacked Proper Internal Controls Over Financial Reporting

According to the complaint, throughout the class period, 3D Systems attested to the accuracy of its financial reporting and disclosure controls and procedures.

On March 1, 2021, 3D Systems issued a press release announcing a delay in filing their 10-K annual report for the fiscal year ended December 31, 2020. Specifically, "the delay in filing is primarily related to the presentation of cash flows associated with the divestiture process for its Cimatron and GibbsCam software business." Further, "the company discovered certain internal control deficiencies. As a result, the company will report material weaknesses in internal controls in its fiscal 2020 Annual Report on Form 10-K." On March 2, 2021, 3D Systems filed a NT-10-K with the SEC, stating that their 10-K filing would be delayed for the reasons stated in their March 1 release. On this news, 3D Systems stock price fell $7.62 per share, or almost 20%, to close at $31.17 per share on March 2, 2021.

If you purchased shares of 3D Systems Corp. (DDD) between May 6, 2020 and March 1, 2021, you have until June 8, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against 3D Systems Corp. Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the FS KKR Capital Corp. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired FS KKR Capital (NYSE: FSK) securities between May 8, 2024 and February 25, 2026. FS KKR Capital is a private credit firm, also known as Business Development Company, which specializes in making private loans to companies.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Ro...

Robbins LLP Urges GOSS Stockholders to Contact the Firm for Information About the Class Action Against Gossamer Bio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) associated with interstitial lung disease.For more information, submit a form, email att...

Robbins LLP Urges IBRX Stockholders to Contact the Firm for Information About the Class Action Against ImmunityBio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? January 19, 2026 – March 25, 202...
Back to Newsroom